A Methodology Study To Evaluate Cerebrospinal Fluid Acetylcholine Following A Single Dose Administration Of Donepezil In Healthy Subjects.

Trial Profile

A Methodology Study To Evaluate Cerebrospinal Fluid Acetylcholine Following A Single Dose Administration Of Donepezil In Healthy Subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Mar 2010

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease
  • Focus Pharmacodynamics
  • Sponsors Pfizer
  • Most Recent Events

    • 03 Mar 2010 Actual patient number (12) added as reported by ClinicalTrials.gov.
    • 03 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top